Alexandria Pharma and Chemical Industries reported a 27% decrease in net annual income to EGP 131.5 mn in its 2020-2021 fiscal year that ended in June, down from EGP 170.05 mn the year before, according to the company’s earnings statement (pdf). Revenues were up 9.5% y-o-y to EGP 1.12 bn, compared with EGP 1.02 bn a year before.

MARKET WATCH-

The EGX30 fell less than 0.1% at today’s close on turnover of EGP 1.75 bn (27.2% above the 90-day average). Local investors were net sellers. The index is down 1.2% YTD.

In the green: Pioneers Holding (+5.3%), Speed Medical (+4.3%) and MM Group (+2.9%).

In the red: CIRA (-2.2%), Fawry (-2.2%) and Cleopatra Hospital (-2.0%).

Tags: